BusinessNovartis Planning To Buy French Advanced Accelerator For $3.9 Million
Swiss pharmaceutical company Novartis today offered to buy French Advanced Accelerator Applications ( AAA ) in a US $ 3,900 million deal in cash, which would strengthen the oncology portfolio of the world’s largest manufacturer of prescription drugs. The Novartis offer represents a premium of 47% over the price of...